Lilly Korea raises doubts over survey of erectile dysfunction products
Published: 2004-06-16 06:58:00
Updated: 2004-06-16 06:58:00
Lilly Korea has recently raised doubts over the reliability of Pfizer Korea’s report citing the survey on the treatment of PDE-5 inhibitors in patients with erectile dysfunction, which was released by Professor Park Nam-chul, Urology Department of Busan University.
Lilly Korea noted that the ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
